SENSEX NIFTY
Ajanta Pharma Quarterly Results, Ajanta Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ajanta Pharma
Ajanta Pharma
BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01031|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 19, 16:30
2329.60
-88.05 (-3.64%)
VOLUME 10,629
LIVE
NSE
Dec 19, 16:30
2327.40
-87.15 (-3.61%)
VOLUME 149,051
Download Annual Report PDF Format 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Ajanta Pharma

------------------- in Rs. Cr. -------------------
Sep '14 Jun '14 Mar '14 Dec '13 Sep '13
Net Sales/Income from operations 331.19 280.79 301.14 292.59 270.75
Other Operating Income 6.11 6.70 9.91 8.26 9.08
Total Income From Operations 337.30 287.49 311.05 300.85 279.83
EXPENDITURE
Consumption of Raw Materials 103.42 57.82 105.86 86.02 57.16
Purchase of Traded Goods 12.89 10.01 14.43 10.14 8.51
Increase/Decrease in Stocks -19.66 12.48 -31.57 -4.69 27.26
Power & Fuel -- -- -- -- --
Employees Cost 44.52 42.84 37.67 38.38 37.35
Depreciation 12.20 12.04 14.89 9.49 8.99
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 85.40 74.64 74.11 73.78 65.39
P/L Before Other Inc. , Int., Excpt. Items & Tax 98.53 77.66 95.66 87.73 75.17
Other Income 15.90 8.69 3.04 4.03 6.30
P/L Before Int., Excpt. Items & Tax 114.43 86.35 98.70 91.76 81.47
Interest 1.34 1.42 2.20 2.18 2.21
P/L Before Exceptional Items & Tax 113.09 84.93 96.50 89.58 79.26
Exceptional Items -- -- -- -- --
P/L Before Tax 113.09 84.93 96.50 89.58 79.26
Tax 34.46 26.21 26.41 27.16 23.45
P/L After Tax from Ordinary Activities 78.63 58.72 70.09 62.42 55.81
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 78.63 58.72 70.09 62.42 55.81
Equity Share Capital 17.68 17.68 17.67 17.67 17.67
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 22.35 16.70 19.94 17.75 15.88
Diluted EPS 22.33 16.68 19.91 17.72 15.86
EPS After Extra Ordinary
Basic EPS 22.35 16.70 19.94 17.75 15.88
Diluted EPS 22.33 16.68 19.91 17.72 15.86
Public Share Holding
No Of Shares (Crores) 0.92 0.93 0.93 0.93 0.93
Share Holding (%) 26.17 26.45 26.40 26.40 26.40
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) 0.14 0.14 0.09 0.08 0.09
- Per. of shares (as a % of the total sh. of prom. and promoter group) 5.57 5.50 3.44 3.25 3.64
- Per. of shares (as a % of the total Share Cap. of the company) 4.11 4.11 2.53 2.39 2.68
b) Non-encumbered
- Number of shares (Crores) 2.45 2.44 2.50 2.50 2.49
- Per. of shares (as a % of the total sh. of prom. and promoter group) 94.43 94.41 96.56 96.75 96.36
- Per. of shares (as a % of the total Share Cap. of the company) 69.72 69.44 71.07 71.21 70.92
Notes
Source : Dion Global Solutions Limited
Quick Links for ajantapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.